Discover 1,461 paid clinical trials in Tacoma, Washington. Search by condition or phase to find a research study near you that matches your needs across various therapeutic areas.
Filter
2
Filter results
Results: 1,461
Abiraterone, Enzalutamide, or Apalutamide in Castrate-sensitive Prostate Cancer.
Location: Seattle WA, Portland OR, Los Angeles CA, St Louis MO,
Sponsor: Sun Pharmaceutical Industries Limited
Sex: Male
Age: 18+
Code: NCT05422911
Phase 2, Recruiting
HealthyTogether: RCT of a Dyadic Weight Management Intervention
for
Obesity, Overweight
Location: Seattle WA, Aurora CO
Sponsor: VA Office of Research and Development
Sex: All
Age: 18+
Code: NCT06619041
Recruiting
Combining a Smartphone App With Medications to Manage Heavy Drinking
for
Alcohol Use Disorder (AUD)
Location: Seattle WA, Salt Lake City UT, Phoenix AZ, Omaha NE,
Sponsor: VA Office of Research and Development
Sex: All
Age: 18 - 70+
Code: NCT06303778
Recruiting
A Single-Arm Phase II Study of Neoadjuvant Intensified Androgen Deprivation (Leuprolide and Abiraterone Acetate) in Combination With AKT Inhibition (Capivasertib) for High-Risk Localized Prostate Cancer With PTEN Loss
for
High-Risk Prostate Cancer
Location: Seattle WA, Portland OR, West Los Angeles CA,
Sponsor: VA Office of Research and Development
Sex: Male
Age: 18+
Code: NCT05593497
Phase 2, Recruiting
High Dose Testosterone for ATM, CDK12 or CHEK2 Altered Prostate Cancers
for
Metastatic Prostate Cancer
Location: Seattle WA, Portland OR, Aurora CO, Kansas City MO,
Sponsor: VA Office of Research and Development
Sex: Male
Age: 18+
Code: NCT05011383
Phase 2, Recruiting
Interested in new trials?
Get alerts for new trials in your area by subscribing now
A Study to Examine the Effects of Novel Therapy Linvoseltamab in Combination With Other Cancer Treatments for Adult Participants With Multiple Myeloma That is Resistant to Current Standard of Care Treatments
for
Multiple Myeloma
Location: Seattle WA, La Jolla CA, Rochester MN, Dallas TX,
Sponsor: Regeneron Pharmaceuticals
Sex: All
Age: 18+
Code: NCT05137054
Phase 1, Recruiting
Functional Improvement in OSA and COPD With a Telehealth LifeStyle and Exercise Intervention
Sponsor: Seattle Institute for Biomedical and Clinical Research
Sex: All
Age: 18+
Code: NCT06390345
Recruiting
Methylphenidate for the Treatment of PTSD With Associated Neurocognitive Complaints
for
Posttraumatic Stress Disorder (PTSD)
Location: Seattle WA, Tuscaloosa AL, Birmingham AL
Sponsor: VA Office of Research and Development
Sex: All
Age: 18 - 65
Code: NCT05776056
Recruiting
A Study to Evaluate Mezigdomide, Bortezomib and Dexamethasone (MEZIVd) Versus Pomalidomide, Bortezomib and Dexamethasone (PVd) in Participants With Relapsed or Refractory Multiple Myeloma (RRMM)
for
Relapsed or Refractory Multiple Myeloma
Location: Seattle WA, Vancouver WA, Salt Lake City UT,
Sponsor: Celgene
Sex: All
Age: 18+
Code: NCT05519085
Phase 3, Recruiting
A Study of First-Line Olomorasib (LY3537982) and Pembrolizumab With or Without Chemotherapy in Patients With Advanced KRAS G12C-Mutant Non-small Cell Lung Cancer
A Study to Compare the Administration of Encorafenib + Binimetinib + Nivolumab Versus Ipilimumab + Nivolumab in BRAF-V600 Mutant Melanoma With Brain Metastases
A Study of Amivantamab and FOLFIRI Versus Cetuximab/Bevacizumab and FOLFIRI in Participants With KRAS/NRAS and BRAF Wild-type Colorectal Cancer Who Have Previously Received Chemotherapy
for
Colorectal Neoplasms
Location: Lacey WA, Seattle WA, Portland OR, Santa Rosa CA,
Sponsor: Janssen Research & Development, LLC
Sex: All
Age: 18+
Code: NCT06750094
Phase 3, Recruiting
A Study to Learn About the Study Medicine Called PF-07248144 in Combination With Fulvestrant in People With HR-positive, HER2-negative Advanced or Metastatic Breast Cancer Who Progressed After a Prior Line of Treatment.
Testing Whether High Dose Chemotherapy and Infusion of the Patients' Own Stem Cells Improves Survival in Patients With Peripheral T-cell Lymphoma Who Achieved a Complete Response at the End of the Initial Chemotherapy